Publications by Marte Kathrine Viken

56 publications found

1. Ramadan DJ, Kichula KM, Tao S, Porfilio T, Lande A, Fluge Ø, Mella O, Strand EB, Saugstad OD, Norman PJ, Lie BA, Viken MK (2025)
   Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
   Brain Behav Immun, 130, 106098
   DOI 10.1016/j.bbi.2025.106098, PubMed 40897283
2. Staff AC, Fjeldstad HE, Olsen MB, Øgaard J, Viken MK, Kramer CSM, Eikmans M, Kroneis T, Sallinger K, Kanaan SB, Sugulle M, Jacobsen DP (2024)
   Foetal Microchimerism Correlates With Foetal-Maternal Histocompatibility Both During Pregnancy and Postpartum
   HLA, 104 (4), e15717
   DOI 10.1111/tan.15717, PubMed 39435899
3. Brun MK, Bjørlykke KH, Viken MK, Stenvik GE, Klaasen RA, Gehin JE, Warren DJ, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Haavardsholm EA, Jahnsen J, Goll GL, Lie BA, Bolstad N, Jørgensen KK, Syversen SW (2023)
   HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
   J Intern Med, 293 (5), 648-655
   DOI 10.1111/joim.13616, PubMed 36843323
4. Viste R, Follin LF, Kornum BR, Lie BA, Viken MK, Thorsby PM, Rootwelt T, Christensen JAE, Knudsen-Heier S (2023)
   Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their non-narcoleptic siblings
   Sleep, 46 (3)
   DOI 10.1093/sleep/zsac316, PubMed 36562330
5. Ueland M, Hajdarevic R, Mella O, Strand EB, Sosa DD, Saugstad OD, Fluge Ø, Lie BA, Viken MK (2022)
   No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
   Transl Psychiatry, 12 (1), 277
   DOI 10.1038/s41398-022-02046-1, PubMed 35821115
6. Hajdarevic R, Lande A, Mehlsen J, Rydland A, Sosa DD, Strand EB, Mella O, Pociot F, Fluge Ø, Lie BA, Viken MK (2022)
   Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci
   Brain Behav Immun, 102, 362-369
   DOI 10.1016/j.bbi.2022.03.010, PubMed 35318112
7. Harrison GF, Leaton LA, Harrison EA, Kichula KM, Viken MK, Shortt J, Gignoux CR, Lie BA, Vukcevic D, Leslie S, Norman PJ (2022)
   Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1
   PLoS Comput Biol, 18 (2), e1009059
   DOI 10.1371/journal.pcbi.1009059, PubMed 35192601
8. Yu E, Ambati A, Andersen MS, Krohn L, Estiar MA, Saini P, Senkevich K, Sosero YL, Sreelatha AAK, Ruskey JA, Asayesh F, Spiegelman D, Toft M, Viken MK, Sharma M, Blauwendraat C, Pihlstrøm L, Mignot E, Gan-Or Z (2021)
   Fine mapping of the HLA locus in Parkinson's disease in Europeans
   NPJ Parkinsons Dis, 7 (1), 84
   DOI 10.1038/s41531-021-00231-5, PubMed 34548497
9. Hajdarevic R, Lande A, Rekeland I, Rydland A, Strand EB, Sosa DD, Creary LE, Mella O, Egeland T, Saugstad OD, Fluge Ø, Lie BA, Viken MK (2021)
   Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci
   Brain Behav Immun, 98, 101-109
   DOI 10.1016/j.bbi.2021.08.219, PubMed 34403736
10. Viste R, Lie BA, Viken MK, Rootwelt T, Knudsen-Heier S, Kornum BR (2021)
    Narcolepsy type 1 patients have lower levels of effector memory CD4⁺ T cells compared to their siblings when controlling for H1N1-(Pandemrix™)-vaccination and HLA DQB1∗06:02 status
    Sleep Med, 85, 271-279
    DOI 10.1016/j.sleep.2021.07.024, PubMed 34388506
11. Viken MK, Pedersen AL, Andersen M, Jensen T, Lie BA, Boulland LML (2021)
    HLA-B*27 typing using a triplex real time PCR in routine laboratory
    HLA, 98 (4), 366-369
    DOI 10.1111/tan.14386, PubMed 34342381
12. Viste R, Viken MK, Lie BA, Juvodden HT, Nordstrand SEH, Thorsby PM, Rootwelt T, Kornum BR, Knudsen-Heier S (2021)
    High nocturnal sleep fragmentation is associated with low T lymphocyte P2Y11 protein levels in narcolepsy type 1
    Sleep, 44 (8)
    DOI 10.1093/sleep/zsab062, PubMed 33710305
13. Tapia G, Mortimer G, Ye J, Mårild K, Chipper-Keating S, Gillard BT, Viken MK, Lie BA, Stene LC, Gillespie KM, Størdal K (2020)
    Maternal Microchimerism in Cord Blood and Risk of Celiac Disease in Childhood
    J Pediatr Gastroenterol Nutr, 71 (3), 321-327
    DOI 10.1097/MPG.0000000000002811, PubMed 32833392
14. Rekeland IG, Fosså A, Lande A, Ktoridou-Valen I, Sørland K, Holsen M, Tronstad KJ, Risa K, Alme K, Viken MK, Lie BA, Dahl O, Mella O, Fluge Ø (2020)
    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
    Front Med (Lausanne), 7, 162
    DOI 10.3389/fmed.2020.00162, PubMed 32411717
15. Lande A, Fluge Ø, Strand EB, Flåm ST, Sosa DD, Mella O, Egeland T, Saugstad OD, Lie BA, Viken MK (2020)
    Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
    Sci Rep, 10 (1), 5267
    DOI 10.1038/s41598-020-62157-x, PubMed 32210306
16. Juvodden HT, Viken MK, Nordstrand SEH, Viste R, Westlye LT, Thorsby PM, Lie BA, Knudsen-Heier S (2020)
    HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives
    Sleep, 43 (3)
    DOI 10.1093/sleep/zsz239, PubMed 31606740
17. Tapia G, Mortimer G, Ye J, Gillard BT, Chipper-Keating S, Mårild K, Viken MK, Lie BA, Joner G, Skrivarhaug T, Njølstad PR, Størdal K, Gillespie KM, Stene LC (2019)
    Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes
    Pediatr Diabetes, 20 (6), 728-735
    DOI 10.1111/pedi.12875, PubMed 31173445
18. Hynne AS, Hopland BI, Jensen T, Boulland LML, Viken MK (2019)
    The novel HLA-A*01 variant, HLA-A*01:308N, detected by sequencing-based typing
    HLA, 94 (3), 312
    DOI 10.1111/tan.13606, PubMed 31144452
19. Hopland BI, Andersen SH, Jensen T, Boulland LML, Viken MK (2019)
    The novel HLA-A*03 variant, HLA-A*03:08:01:02, detected by sequencing-based typing
    HLA, 94 (1), 60-61
    DOI 10.1111/tan.13549, PubMed 30977308
20. Tapia G, Mårild K, Dahl SR, Lund-Blix NA, Viken MK, Lie BA, Njølstad PR, Joner G, Skrivarhaug T, Cohen AS, Størdal K, Stene LC (2019)
    Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes
    Diabetes Care, 42 (4), 553-559
    DOI 10.2337/dc18-2176, PubMed 30692241
21. Størdal K, McArdle HJ, Hayes H, Tapia G, Viken MK, Lund-Blix NA, Haugen M, Joner G, Skrivarhaug T, Mårild K, Njølstad PR, Eggesbø M, Mandal S, Page CM, London SJ, Lie BA, Stene LC (2018)
    Prenatal iron exposure and childhood type 1 diabetes
    Sci Rep, 8 (1), 9067
    DOI 10.1038/s41598-018-27391-4, PubMed 29899542
22. Guderud K, Mæhlen MT, Nordang GBN, Viken MK, Andreassen BK, Molberg Ø, Flåm ST, Lie BA (2018)
    Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis
    J Rheumatol, 45 (9), 1211-1219
    DOI 10.3899/jrheum.170769, PubMed 29858238
23. Lande A, Andersen I, Egeland T, Lie BA, Viken MK (2018)
    HLA -A, -C, -B, -DRB1, -DQB1 and -DPB1 allele and haplotype frequencies in 4514 healthy Norwegians
    Hum Immunol, 79 (7), 527-529
    DOI 10.1016/j.humimm.2018.04.012, PubMed 29684411
24. Vistnes M, Tapia G, Mårild K, Midttun Ø, Ueland PM, Viken MK, Magnus P, Berg JP, Gillespie KM, Skrivarhaug T, Njølstad PR, Joner G, Størdal K, Stene LC (2017)
    Plasma immunological markers in pregnancy and cord blood: A possible link between macrophage chemo-attractants and risk of childhood type 1 diabetes
    Am J Reprod Immunol, 79 (3)
    DOI 10.1111/aji.12802, PubMed 29266506
25. Popperud TH, Viken MK, Kerty E, Lie BA (2017)
    Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset
    PLoS One, 12 (10), e0186383
    DOI 10.1371/journal.pone.0186383, PubMed 29036181
26. Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E, UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D et al. (2017)
    HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry
    HLA, 90 (4), 228-233
    DOI 10.1111/tan.13076, PubMed 28695657
27. Dahl J, Refsum E, Ahlen MT, Egeland T, Jensen T, Viken MK, Stuge TB, Acharya G, Husebekk A, Skogen B, Tiller H (2017)
    Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data
    J Reprod Immunol, 122, 1-9
    DOI 10.1016/j.jri.2017.06.003, PubMed 28686909
28. Viken MK, Flåm ST, Skrivarhaug T, Amundsen SS, Sollid LM, Drivvoll AK, Joner G, Dahl-Jørgensen K, Lie BA (2017)
    HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease
    HLA, 89 (5), 278-284
    DOI 10.1111/tan.12986, PubMed 28247576
29. Mårild K, Vistnes M, Tapia G, Midttun Ø, Ueland PM, Viken MK, Magnus P, Berg JP, Stene LC, Størdal K (2016)
    Midpregnancy and cord blood immunologic biomarkers, HLA genotype, and pediatric celiac disease
    J Allergy Clin Immunol, 139 (5), 1696-1698
    DOI 10.1016/j.jaci.2016.10.016, PubMed 27865861
30. Gabrielsen IS, Viken MK, Amundsen SS, Helgeland H, Holm K, Flåm ST, Lie BA (2016)
    Autoimmune risk variants in ERAP2 are associated with gene-expression levels in thymus
    Genes Immun, 17 (7), 406-411
    DOI 10.1038/gene.2016.39, PubMed 27829666
31. Bruserud Ø, Oftedal BE, Landegren N, Erichsen MM, Bratland E, Lima K, Jørgensen AP, Myhre AG, Svartberg J, Fougner KJ, Bakke Å, Nedrebø BG, Mella B, Breivik L, Viken MK, Knappskog PM, Marthinussen MC, Løvås K, Kämpe O, Wolff AB, Husebye ES (2016)
    A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1
    J Clin Endocrinol Metab, 101 (8), 2975-83
    DOI 10.1210/jc.2016-1821, PubMed 27253668
32. Gabrielsen IS, Amundsen SS, Helgeland H, Flåm ST, Hatinoor N, Holm K, Viken MK, Lie BA (2016)
    Genetic risk variants for autoimmune diseases that influence gene expression in thymus
    Hum Mol Genet, 25 (14), 3117-3124
    DOI 10.1093/hmg/ddw152, PubMed 27199374
33. Liaskou E, Klemsdal Henriksen EK, Holm K, Kaveh F, Hamm D, Fear J, Viken MK, Hov JR, Melum E, Robins H, Olweus J, Karlsen TH, Hirschfield GM (2015)
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
    Hepatology, 63 (5), 1608-19
    DOI 10.1002/hep.28116, PubMed 26257205
34. Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP, Fleishman SJ, Banka S, Newman WG, Sewell WA, Sozaeva LS, Zayats T, Haugarvoll K, Orlova EM, Haavik J, Johansson S, Knappskog PM, Løvås K, Wolff AS, Abramson J, Husebye ES (2015)
    Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases
    Immunity, 42 (6), 1185-96
    DOI 10.1016/j.immuni.2015.04.021, PubMed 26084028
35. Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
    Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
    BMC Cancer, 14, 845
    DOI 10.1186/1471-2407-14-845, PubMed 25407022
36. Vidan-Jeras B, Buhler S, Dubois V, Grubic Z, Ivanova M, Jaatinen T, Ligeiro D, Lokki ML, Papasteriades C, Poli F, Spyropoulou-Vlachou M, Tordai A, Viken MK, Wenda S, Nunes JM, Sanchez-Mazas A, Tiercy JM (2014)
    Resolution of HLA-B*44:02:01G, -DRB1*14:01:01G and -DQB1*03:01:01G reveals a high allelic variability among 12 European populations
    Tissue Antigens, 84 (5), 459-64
    DOI 10.1111/tan.12422, PubMed 25209151
37. Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF (2014)
    Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general
    J Neuroimmunol, 274 (1-2), 174-9
    DOI 10.1016/j.jneuroim.2014.06.024, PubMed 25037176
38. Amundsen SS, Viken MK, Sollid LM, Lie BA (2014)
    Coeliac disease-associated polymorphisms influence thymic gene expression
    Genes Immun, 15 (6), 355-60
    DOI 10.1038/gene.2014.26, PubMed 24871462
39. Maehlen MT, Olsen IC, Andreassen BK, Viken MK, Jiang X, Alfredsson L, Källberg H, Brynedal B, Kurreeman F, Daha N, Toes R, Zhernakova A, Gutierrez-Achury J, de Bakker PI, Martin J, Teruel M, Gonzalez-Gay MA, Rodríguez-Rodríguez L, Balsa A, Uhlig T, Kvien TK, Lie BA (2013)
    Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis
    Ann Rheum Dis, 74 (4), 762-8
    DOI 10.1136/annrheumdis-2013-204173, PubMed 24336335
40. Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, Mustelin T, Tasken K, Tautz L, Rickert RC, Lie BA (2013)
    The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses
    Hum Immunol, 74 (5), 574-85
    DOI 10.1016/j.humimm.2012.12.017, PubMed 23333624
41. Nordang GB, Carpenter D, Viken MK, Kvien TK, Armour JA, Lie BA (2012)
    Association analysis of the CCL3L1 copy number locus by paralogue ratio test in Norwegian rheumatoid arthritis patients and healthy controls
    Genes Immun, 13 (7), 579-82
    DOI 10.1038/gene.2012.30, PubMed 22785612
42. Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF (2012)
    Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population
    PLoS One, 7 (5), e36603
    DOI 10.1371/journal.pone.0036603, PubMed 22590574
43. Nordang GB, Viken MK, Amundsen SS, Sanchez ES, Flatø B, Førre OT, Martin J, Kvien TK, Lie BA (2011)
    Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts
    Rheumatology (Oxford), 51 (4), 619-26
    DOI 10.1093/rheumatology/ker364, PubMed 22179739
44. Martín JE, Alizadeh BZ, González-Gay MA, Balsa A, Pascual-Salcedo D, González-Escribano MF, Rodriguez-Rodriguez L, Fernández-Gutiérrez B, Raya E, Coenen MJ, van Riel P, Radstake TR, Kvien TK, Viken MK, Lie BA, Koeleman BP, Martín J (2011)
    Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region
    J Rheumatol, 38 (11), 2290-6
    DOI 10.3899/jrheum.110361, PubMed 21965649
45. Rodríguez-Rodríguez L, Taib WR, Topless R, Steer S, González-Escribano MF, Balsa A, Pascual-Salcedo D, González-Gay MA, Raya E, Fernandez-Gutierrez B, González-Álvaro I, Bottini N, Witte T, Viken MK, Coenen MJ, van Riel PL, Franke B, den Heijer M, Radstake TR, Wordsworth P, Lie BA, Merriman TR, Martín J (2011)
    The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples
    Arthritis Rheum, 63 (2), 365-72
    DOI 10.1002/art.30145, PubMed 21279993
46. Mero IL, Ban M, Lorentzen ÅR, Smestad C, Celius EG, Sæther H, Saeedi H, Viken MK, Skinningsrud B, Undlien DE, Aarseth J, Myhr KM, Granum S, Spurkland A, Sawcer S, Compston A, Lie BA, Harbo HF (2010)
    Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus
    Genes Immun, 12 (3), 191-8
    DOI 10.1038/gene.2010.59, PubMed 21179112
47. Viken MK, Blomhoff A, Olsson M, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA (2009)
    Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex
    Genes Immun, 10 (4), 323-33
    DOI 10.1038/gene.2009.13, PubMed 19295542
48. Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Førre ØT, Helgetveit K, Kvien TK, Lie BA (2009)
    Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand
    Rheumatology (Oxford), 48 (4), 367-70
    DOI 10.1093/rheumatology/ken512, PubMed 19208686
49. Viken MK, Sollid HD, Joner G, Dahl-Jørgensen K, Rønningen KS, Undlien DE, Flatø B, Selvaag AM, Førre Ø, Kvien TK, Thorsby E, Melms A, Tolosa E, Lie BA (2007)
    Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis
    Hum Immunol, 68 (9), 748-55
    DOI 10.1016/j.humimm.2007.05.009, PubMed 17869649
50. Viken MK, Olsson M, Flåm ST, Førre O, Kvien TK, Thorsby E, Lie BA (2007)
    The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material
    Tissue Antigens, 70 (3), 190-7
    DOI 10.1111/j.1399-0039.2007.00871.x, PubMed 17661906
51. Lie BA, Viken MK, Akselsen HE, Flåm ST, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE (2007)
    Association analysis in type 1 diabetes of the PRSS16 gene encoding a thymus-specific serine protease
    Hum Immunol, 68 (7), 592-8
    DOI 10.1016/j.humimm.2007.03.009, PubMed 17584581
52. Lie BA, Viken MK, Odegård S, van der Heijde D, Landewé R, Uhlig T, Kvien TK (2007)
    Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study
    Ann Rheum Dis, 66 (12), 1604-9
    DOI 10.1136/ard.2006.067892, PubMed 17472988
53. Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V, Sollid LM, Førre OT, Thorsby E, Smerdel A, Lie BA (2005)
    Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases
    Genes Immun, 6 (3), 271-3
    DOI 10.1038/sj.gene.6364178, PubMed 15759012
54. Haslekås C, Grini PE, Nordgard SH, Thorstensen T, Viken MK, Nygaard V, Aalen RB (2003)
    ABI3 mediates expression of the peroxiredoxin antioxidant AtPER1 gene and induction by oxidative stress
    Plant Mol Biol, 53 (3), 313-26
    DOI 10.1023/b:plan.0000006937.21343.2a, PubMed 14750521
55. Haslekås C, Viken MK, Grini PE, Nygaard V, Nordgard SH, Meza TJ, Aalen RB (2003)
    Seed 1-cysteine peroxiredoxin antioxidants are not involved in dormancy, but contribute to inhibition of germination during stress
    Plant Physiol, 133 (3), 1148-57
    DOI 10.1104/pp.103.025916, PubMed 14526116
56. Lie BA, Viken MK, Egeland T, Undlien DE, Vaage JT (2021)
    OBITUARY Erik Thorsby (1938-2021)
    HLA, 98 (1), 3-4
    DOI 10.1111/tan.14290